Davenport & Co »

Phathom Pharmaceuticals shares owned by Davenport & Co

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Davenport & Co from 13F filings

Historical chart of Davenport & Co investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Davenport & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Davenport & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $91k 10k 9.13

More positions owned by Davenport & Co

Brookfield Corp Cl A Ltd Vt Sh (BN)
Markel Corporation (MKL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
Apple (AAPL)
Walt Disney Company (DIS)
Martin Marietta Materials (MLM)
JPMorgan Chase & Co. (JPM)
Lamar Advertising Cl A (LAMR)
Meta Platforms Cl A (META)
Bristol Myers Squibb (BMY)
Watsco, Incorporated (WSO)

View all positions for Davenport & Co

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
NEA Management Company
Vanguard Group
Avidity Partners Management
Jennison Associates
Gilder, Gagnon, Howe & Co
683 Capital Management
Decheng Capital
Newtyn Management
Jacobs Levy Equity Management
Kennedy Capital Management
Jennifer Ranahan
Propel Bio Management

View all funds holding Phathom Pharmaceuticals